Erenumab Reduces Flushing and Erythema in Rosacea

A calcitonin gene-related peptide inhibitor that is FDA-approved for migraine prevention showed early promise against treatment-resistant redness and flushing of rosacea.
Medscape Medical News

source https://www.medscape.com/viewarticle/erenumab-reduces-persistent-flushing-and-erythema-rosacea-2024a10007vq?src=rss